Recall archive / FDA drug enforcement

Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood ... — FDA record D-1182-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 10, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085
Reason: Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Classification: Class II
Recalling firm: Wedgewood Village Pharmacy, LLC
Quantity: 24 bottles
Agency-reported status: Terminated
Source record identifier: D-1182-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22; Lot#: 000-03780127, Exp Date: 08/6/22; Lot#: 000-03794760, Exp Date: 08/6/22; Lot#: 000-03892723, Exp Date: 09/1/22; Lot#: 000-03641022, Exp Date: 06/17/22; Lot#: 000-03693714, Exp Date: 06/28/22; Lot#: 000-03770510, Exp Date: 08/6/22; Lot#: 000-03852462, Exp Date: 09/1/22; Lot#: 000-03840601, Exp Date: 09/1/22; Lot#: 000-03706934, Exp Date: 06/28/22; Lot#: 000-03850609, Exp Date: 09/1/22; Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22; Lot#: 000-03693748, Exp Date: 06/28/22; Lot#: 000-03904403, Exp Date: 09/1/22; Lot#: 000-03799564, Exp Date: 08/06/22; Lot#: 000-03723022, Exp Date: 06/28/22; Lot#: 000-03872892, Exp Date: 09/01/22; Lot#: 000-03885204, Exp Date: 09/01/22; Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22;

Label field

Details supplied by the agency

Lot, code or applicability

Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22; Lot#: 000-03780127, Exp Date: 08/6/22; Lot#: 000-03794760, Exp Date: 08/6/22; Lot#: 000-03892723, Exp Date: 09/1/22; Lot#: 000-03641022, Exp Date: 06/17/22; Lot#: 000-03693714, Exp Date: 06/28/22; Lot#: 000-03770510, Exp Date: 08/6/22; Lot#: 000-03852462, Exp Date: 09/1/22; Lot#: 000-03840601, Exp Date: 09/1/22; Lot#: 000-03706934, Exp Date: 06/28/22; Lot#: 000-03850609, Exp Date: 09/1/22; Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22; Lot#: 000-03693748, Exp Date: 06/28/22; Lot#: 000-03904403, Exp Date: 09/1/22; Lot#: 000-03799564, Exp Date: 08/06/22; Lot#: 000-03723022, Exp Date: 06/28/22; Lot#: 000-03872892, Exp Date: 09/01/22; Lot#: 000-03885204, Exp Date: 09/01/22; Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22;

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Products were distributed nationwide in the USA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: Jul 13, 2022
Recall initiation date: Jun 10, 2022
Center classification date: Jul 7, 2022
Termination date: Feb 16, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.